Infectious Chlamydia trachomatis (LGV strain), obligate intracellular bacteria, stimulated human peripheral blood lymphocytes to proliferate and secrete immunoglobulins in vitro. In contrast, mockinfected preparations were unable to induce similar responses in peripheral blood lymphocytes. Although levels of immunoglobulin secreted into the media of LGV-stimulated cultures were greater than 10 ,ug/ml, we estimated that less than 1% of these molecules were directed against the bacteria itself, suggesting polyclonal antibody production. To further define the mechanisms by which chlamydiae perturb the human immune system, we have undertaken an investigation of both the antibody and proliferative responses of normal human peripheral blood lymphocytes (PBL) to C. trachomatis in vitro. Our results demonstrate that C. trachomatis is a potent polyclonal B-cell activator of human PBL for both immunoglobulin secretion and DNA synthesis. We define several of the mechanisms of this activation and compare responses induced by C. trachomatis with those stimulated by two other polyclonal activators, pokeweed mitogen (PWM) and Staphylococcus aiureus Cowan I.
Infectious Chlamydia trachomatis (LGV strain), obligate intracellular bacteria, stimulated human peripheral blood lymphocytes to proliferate and secrete immunoglobulins in vitro. In contrast, mockinfected preparations were unable to induce similar responses in peripheral blood lymphocytes. Although levels of immunoglobulin secreted into the media of LGV-stimulated cultures were greater than 10 ,ug/ml, we estimated that less than 1% of these molecules were directed against the bacteria itself, suggesting polyclonal antibody production. Since stimulation with Formalin-killed bacteria resulted in comparable numbers of plaque-forming cells (PFC) as infectious particles, we concluded that the polyclonal immunoglobulin response was not dependent on the in vitro chlamydial infectious process. The polyclonal PFC response induced by LGV was highly sensitive to monocyte inhibition. Although LGV induced proliferation of predominantly B cells, the numbers of generated PFC was increased by the addition of autologous T cells. Neither lymphocyte proliferation nor PFC responses of normal human volunteers correlated significantly with the presence or titer of antichlamydial antibodies in their sera.
Chlamydia trachomatis are obligate intracellular bacteria whose various serotypes are associated with a variety of human diseases (e.g., trachoma, inclusion conjunctivitis, nongonococcal urethritis, lymphogranuloma venereum [ LGV], and infant pneumonia) (37) . Chlamydiae have a complex life cycle involving an infectious nonmetabolically active form (elementary body) and a noninfectious metabolically active stage (reticulate body). This growth pattern may be responsible for latency or inapparent infections as well as chronic, persistent infections that are commonly observed in human chlamydia-associated diseases.
The role of the immune system in protecting individuals against reinfection or in resolving ongoing infections by chlamydiae is unclear. Both humoral and cell-mediated immunity induced by chlamydiae have been proposed as major factors involved in limiting chlamydial infections in animals (24, 25, 43, 47) . However, caution should be exercised when extrapolating from these systems to humans; many of the strains of chlamydiae as well as the natural history of illness in animal models differ in human infections (23, 31, 37) .
Chlamydiae can induce human cell-mediated immune responses in vivo (Frei skin test for delayed-type hypersensitivity) and in vitro (blast transformation and chlamydiacidal effect by polymorphonuclear leukocytes) (8, 15, 49) . Antibodies to C. trachomatis have been detected in serum, tears, and genital secretions in humans. Individuals with the disease LGV often show profound hypergammaglobulinemia, especially of the immunoglobulin A (IgA) isotype (26) . Elevated serum immunoglobulin (total immunoglobulin) is also characteristic of infant pneumonitis associated with C. trachomatis infections (4, 44) . Such infants possess dramatic elevations of peripheral blood B lymphocytes and plasma cells and secrete large quantities of immunoglobulins sponta-neously in vitro (D. Levitt, R. W. Newcomb, and M. 0. Beem, Clin. Immunol. Immunopathol., in press).
To further define the mechanisms by which chlamydiae perturb the human immune system, we have undertaken an investigation of both the antibody and proliferative responses of normal human peripheral blood lymphocytes (PBL) to C. trachomatis in vitro. Our results demonstrate that C. trachomatis is a potent polyclonal B-cell activator of human PBL for both immunoglobulin secretion and DNA synthesis. We define several of the mechanisms of this activation and compare responses induced by C. trachomatis with those stimulated by two other polyclonal activators, pokeweed mitogen (PWM) and Staphylococcus aiureus Cowan I.
MATERIALS AND METHODS
Isolation and purification of chlamydiae. The LGV strain (L2/434/Bu) of C. trachomatis was obtained from J. Schachter, University of California, San Francisco. McCoy cells, a mouse fibroblast cell line, were infected with 10 50% infectious doses of C. trachomatis such that more than 95% of the host cells were infected, according to Hatch's method for titrating chlamydial infectivity (16) . Monolayers were incubated for 1.5 h at 37°C on a shaker to allow attachment of bacteria. Fifteen milliliters of growth medium (modified Eagle medium containing 10% fetal calf serum [FCS] and 250 p.g of streptomycin sulfate per ml) plus 0.5 ,ug of cyclohexi-methylglucamine diatrizoate; E. R. Squibb & Sons, Princeton, N.J.) centrifuged at 90,000 x g for 2 h was used to purify LGV or MI instead of a 5 to 60% continuous gradient centrifuged for 4 h at 100,000 x g.
The interface between 60 and 32% containing LGV elementary bodies was collected, pooled, washed twice, and suspended in sucrose-phosphate buffer (0.2 M sucrose in 0.2 M potassium phosphate buffer [pH 7.2]) with 0.5% human serum albumin. The samples were then divided into portions and stored at -70°C.
Preparation of PBMC. Peripheral blood from normal adult donors was sedimented on Ficoll-Hypaque gradients to separate mononuclear leukocytes (PBMC) (5) . Samples were obtained from healthy adult blood bank donors (age and sex unknown) and laboratory personnel (male to female ratio, 60:40; ages, 22 to 60 years). Cells from a single known donor used in different experiments were usually obtained on different days. Cells were washed extensively with Hanks balanced salt solution plus 10% FCS and suspended in complete medium (RPMI 1640 containing 10% FCS, 2 mM Lglutamine, 50 pLM 2-mercaptoethanol, and 250 ,ug of streptomycin sulfate per ml).
In most experiments, monocytes were removed from PBMC by either adherence to plastic for 1 h at 37°C or passage through Sephadex G-10 (18). Nonadherent cells contained fewer than 5% monocytes, as determined by fluorescent staining with anti-human monocyte antibody OKM1.
Fluorescent staining of cells. Characterization of PBMC subpopulations was performed by reacting PBMCs with fluorochrome-conjugated antibodies (13) . B cells were detected by using fluorescein-conjugated goat antihuman immunoglobulin (polyvalent; Meloy Lab; Springfield, Va.) or antihuman pL (p.-chain specific; affinity purified); percentages of total T cells and monocytes/null cells were determined by using monoclonal antibodies OKT3 and OKM1, respectively (both from Ortho Diagnostics, Raritan, N.J.), followed by fluorescein-conjugated goat antimouse IgG (Bionetics, Kensington, Md.) absorbed twice with human gamma globulins.
Separation of T-and B-cell fractions. T-and B-cell fractions were obtained by rosetting monocyte-depleted PBMC with aminoethylisothiouronium bromide-treated sheep erythrocytes, followed by separation on Ficoll-Hypaque gradients (33 (27) 120 (7) 230 (35) (Table 2) . In all individuals, IgM-PFC accounted for more than 60% of the total PFC. In contrast, IgM-PFC were usually less than 50% of the total PFC induced by either S. aureus or PWM (Table 2) . (45) . Thus, we investigated the importance of monocytes during C. trachoinaitis-stimulated PFC responses. Monocytes were removed from the PBMC fraction by either passage through Sephadex G-10 or adherence to plastic dishes; the eluate or nonadhered cells represented the monocyte-depleted fraction. Greater than 90% of plastic-adhered cells were nonspecific esterase positive. As shown in Fig. 1 , generation of PFC after C. trachomatis stimulation was significantly greater in monocyte-depleted cultures than undepleted samples (P < 0.05). In both cases, there was a significant increase in PFC after C. tirachonaitis stimulation compared with unstimulated MI cultures (P < 0.05 for both).
A similar effect of monocytes on S. (lureius-driven PFC formation was also observed (Fig. 1) . Significantly fewer PFC occurred before depletion of adherent cells than after passage through G-10 columns (P < 0.01). In contrast, removal of monocytes did not affect PFC generation by PWM-stimulated PBL ( Fig. 1; P The number of PFC increased, however, after T ce added to cultures and was optimal at T to B cell rati for S. aureus and 3:7 or lower for PWM. Thus, T cytes markedly enhanced PFC development after C matis stimulation in a manner similar to the better ci ized bacterial activator, S. aureus (19 a Final dilutions are indicated in Table 2 We examined whether high or low PFC and proliferative responses induced by chlamydiae in vitro might be due to prior exposure to the bacteria. We therefore compared serum endpoint antichlamydial antibody titers (4) (25) , and lymphoid hyperplasia is a significant component of LGV (39) . Antibodies against chlamydiae and their surface components have been detected in tears, genital secretions, and serum of infected individuals (25, 37) . During early infancy, a period normally associated with immune hyporesponsiveness, chlamydial pneumonia is associated with pronounced hyperglobulinemia (4, 44) and excessive numbers of B lymphocytes and plasma cells in the peripheral blood (Levitt et al., in press ). This latter finding prompted the present study.
Our results demonstrate that C. trachomatis can induce Bcell differentiation to immunoglobulin-secreting plasmacytes when added to cultures of PBL. These bacteria stimulate Bcell proliferation and, in the presence of T lymphocytes, secretion of large quantities of immunoglobulins. In this manner, chlamydiae behave similarly to the extracellular bacteria S. aureus Cowan I (46) . Few of the antibodies secreted are directed against the bacteria themselves.
The peak mitogenic response to chlamydiae preceded maximum immunoglobulin secretion in vitro by 2 days. This mitogenic effect occurs predominantly in the B-cell fraction. Such circumstances usually suggest the necessity of DNA synthesis for B-cell differentiation (11) . Although certain polyclonal activators do induce B-lymphocyte proliferation (3, 46) , others stimulate substantial differentiation with minimal thymidine incorporation (1, 34 Table 3 ) and the proliferative response (see Table  6 ) from each volunteer (n = 12) were compared. The (12) . The number of PFC in C. trachomatis-stimulated cultures was, however, enhanced by the addition of autologous T cells. The optimal T to B cell ratio for generation of PFC was 7:3 for both bacterial polyclonal activators (S. aureus and C. trachomatis). In contrast, a lower ratio of T to B cells was necessary for maximum development of PFC in PWM-stimulated cultures. The difference in optimum T to B cell ratios between PWM cultures versus S. aureus-and C. trachomatis-stimulated cultures could be due to the induction of suppressor T cells in the former cultures which would reduce the PFC response (46 [32] in a manner analogous to S. aureus protein A [36] ) before the induction of proliferation. This situation, along with our finding of Tcell involvement in the generation of immunoglobulin-secreting cells, supports a two-signal model of B-cell differentiation into plasma cells, as previously postulated for both murine and human systems (7, 12, 40 (21, 29, 46) . It is also possible that precursor B cells capable of secreting antichlamydial antibodies are present in very low frequencies in peripheral blood. To determine whether different mechanisms exist for polyclonal versus specific activation by C. trachomatis, it would be important to examine responses induced by chlamydiae using cells from other lymphoid organs (e.g., spleen, tonsils, lymph nodes) which contain larger percentages and possibly a greater diversity of B lymphocytes.
Our data show that whereas a highly significant correlation exists between proliferative and PFC responses induced by C. trachomatis in a single individual, these parameters have no relationship to a person's serum anti-L2 antibody titer. These results agree partially with the findings of Hanna et al. (15) , indicating that in an individual, antichlamydial antibody titers do not aid in predicting the results of proliferative responses. In contrast to their study, we could find no correlation between serum antichlamydial antibodies and thymidine incorporation in our population analyzed as a whole. In addition, Brunham and colleagues (8) suggested that C. trachomatis was not mitogenic for PBL from sexually inexperienced, seronegative adults. No prior infectious histories were obtained from our volunteers; however, sera from several individuals were assayed multiple times for antibodies against chlamydiae with identical results. It is unclear why our findings differ from the results of Brunham et al. in this regard; possible explanations include different culture and assay systems, sample size, and study population.
Since the outer membrane of C. trachomatis is similar to that of gram-negative bacteria, it seemed possible that LPS, a component of gram-negative bacterial cell walls, was responsible for lymphocyte activation in this system, similar to murine studies using E. coli LPS (2, 17) . This hypothesis appears unlikely because (i) lipid A has not been clearly demonstrated in chlamydiae (10; L. F. Guymon, P. B. Wyrick, and C. H. Davis, Abstr. Annu. Meet. Am. Soc. Microbiol. 1983, B62, p. 33); (ii) the 2-keto-3-deoxyoctanoic acid found on C. trachomatis by Dhir et al. (10) differed significantly from similar molecules found on Salmonella enteritides LPS; (iii) human PBL proliferate poorly in response to LPS under our culture conditions (29) ; (iv) LPS is heat stable (boiling for 10 min), whereas stimulatory effects of C. ti'achomatis were completely abolished by boiling for 5 min (J. Bard and D. Levitt, Fed. Proc. 42:864, 1983) .
Several microorganisms or their products can induce polyclonal immunoglobulin secretion in vitro. In each instance, adherent cells or monocytes inhibit maximum responses (3, 20) . We have also found this situation to exist in (22, 48) , so precedence for the former possibility exists.
Cell wall components of certain bacteria (e.g., streptococci) may persist for long periods in macrophages. This situation has been associated with modulation of host immune responses and may contribute to the pathogenesis of bacterial-induced chronic diseases (42) . Since noninfectious C. trachomatis can perturb the human immune system in vitro, the persistence of elevated immunoglobulins against chlamydiae in sera of people months and even years after initial exposure may result from ongoing reexposure to sequestered, slowly released bacteria. Our system will allow a closer examination of the means by which these intracellular bacteria interact with the human immune system.
